Differences in iron metabolism appear to underlie this discrepancy, as M-CLL cells presented increased expression of TFRC/CD71 and DMT1, leading to increased intracellular Fe2+ levels. The gene discussed is SLC11A2; the disease is B-cell chronic lymphocytic leukemia.